To determine whether DMF may exert its therapeutic effects in EBA through activation of HCA2 on infiltrating cell populations, we profiled the spatiotemporal dynamics of Hca2 expression in the peripheral blood and in the skin in the course of experimental EBA. Here, HCAR2 is linked to acquired epidermolysis bullosa.